Storage Condition
Store at refrigerator (2-8°C) for long term storage
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Enzalutamide-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Enzalutamide-d3 usage and description
MDV 3100-d3 is a drug that is used in the treatment of prostate cancer. It is a synthetic androgen receptor inhibitor that binds to the androgen receptor and prevents the binding of testosterone and dihydrotestosterone (DHT) to the receptor. This drug is also known as enzalutamide, and it is a deuterated form of MDV 3100, which is a non-deuterated analog of enzalutamide.
MDV 3100-d3 has a half-life of approximately 5 days, and it is metabolized mainly in the liver. The drug is eliminated from the body through urine and feces. MDV 3100-d3 is an oral medication that is taken once a day, and it is available in capsule form. The recommended dosage of the drug is 160 mg per day.
The chemical formula of MDV 3100-d3 is C21H16F4N4O2D3, and it has a molecular weight of 464.5 g/mol. The drug is a white to off-white crystalline powder that is slightly soluble in water and freely soluble in organic solvents such as methanol, ethanol, and acetone.
MDV 3100-d3 has been shown to be effective in the treatment of metastatic castration-resistant prostate cancer when used in combination with other therapies such as chemotherapy or radiation therapy. The drug has also been shown to have a favorable safety profile, with most adverse effects being mild to moderate in severity.
